| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 30 | 23 | 30 | 36 | 40 | 51 | 0 |
| Expenses | 30 | 22 | 27 | 28 | 32 | 41 | 0 |
| EBITDA | 0 | 0 | 3 | 8 | 9 | 10 | 0 |
| Operating Profit % | 1 % | 1 % | 10 % | 22 % | 21 % | 20 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 3 | 7 | 8 | 10 | 0 |
| Tax | 0 | 0 | 1 | 2 | 2 | 2 | 0 |
| Net Profit | 0 | 0 | 2 | 5 | 6 | 7 | 0 |
| EPS in ₹ | 1.77 | 0.88 | 42.54 | 6.72 | 5.36 | 6.26 | 0.00 |
Shelter Pharma
Shelter Pharma
31.80
0.00
(0.00%)
Market Cap
53.50 Cr
PE Ratio
7.40
Volume
0.00
Day High - Low
- - -
52W High-Low
50.00 - 26.50
Key Fundamentals
Market Cap
53.50 Cr
EPS
6.26
PE Ratio
7.40
PB Ratio
0.89
Book Value
35.90
EBITDA
10.10
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
16.94
Debt to Equity
0.02
Actual
Company News
View All News
Shelter Pharma receives a one-year rate contract work order from Verka Dairies for supply of veterinary medicines, with delivery terms and payment conditions specified.
Shelter Pharma receives repeat international purchase orders worth USD 84,450 from Taha Drugs & Chemicals Co. Ltd for nutraceutical products, reinforcing its global business presence.
Shelter Pharma Limited converted 2,79,000 warrants into 1,14,000 equity shares on May 01, 2026, raising Rs. 36,12,375 from three non-promoter investors. Paid-up capital increased to Rs. 167,257,920.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,878.20 | #1 4,50,643.09 | 40.81 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 64.89 | |
6,760.50 | 1,79,470.03 | 74.13 | 9,712.00 | 18.67 | 2,191 | -1.02 | 64.06 | |
4,405.70 | 1,49,108.91 | 65.68 | 11,539.40 | 6.99 | 1,911 | 26.24 | 58.52 | |
1,432.10 | 1,15,682.27 | 30.09 | 27,711.70 | -2.46 | 3,783 | -55.32 | 69.78 | |
1,336.70 | 1,11,566.73 | 26.16 | 33,593.30 | -0.44 | 3,998 | -86.05 | 59.87 | |
2,276.20 | 1,04,032.18 | #1 19.28 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 46.11 | |
2,503.00 | 1,03,325.11 | 56.36 | 12,744.20 | 20.90 | 2,007 | 7.65 | 73.37 | |
1,011.70 | 1,01,800.69 | 19.85 | 23,511.00 | 18.55 | 4,615 | -0.32 | 69.47 | |
1,511.80 | 87,805.59 | 25.16 | 32,345.60 | 9.43 | 3,484 | 7.59 | 73.83 | |
1,323.60 | 71,455.42 | 79.78 | 6,812.90 | #1 21.03 | 884 | 21.18 | 80.26 |
Growth Rate
Revenue Growth
26.75 %
Net Income Growth
16.13 %
Cash Flow Change
379.59 %
ROE
-2.14 %
ROCE
-1.88 %
EBITDA Margin (Avg.)
-7.19 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 11 | 10 | 13 | 21 | 38 | 48 |
| Fixed Assets | 2 | 2 | 2 | 2 | 4 | 6 |
| Current Assets | 8 | 8 | 10 | 19 | 30 | 33 |
| Capital Work in Progress | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 9 | 9 | 11 | 20 | 34 | 42 |
| Total Equity & Liabilities | 11 | 10 | 13 | 21 | 38 | 48 |
| Current Liabilities | 4 | 3 | 4 | 6 | 2 | 5 |
| Non Current Liabilities | 0 | 0 | 0 | 1 | 1 | 1 |
| Total Equity | 7 | 7 | 9 | 15 | 36 | 43 |
| Reserve & Surplus | 7 | 7 | 8 | 7 | 24 | 31 |
| Share Capital | 1 | 1 | 1 | 8 | 12 | 12 |
Cash Flow
| Cash Flow | 2017 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 5 | -2 |
| Investing Activities | 0 | 0 | 0 | -1 | 0 | -4 | -7 |
| Operating Activities | 0 | -0 | -0 | 1 | 0 | -2 | 6 |
| Financing Activities | 0 | 0 | 1 | 0 | 0 | 11 | 0 |
Share Holding
| % Holding | Aug 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Aug 2025 | Sept 2025 | Oct 2025 | Nov 2025 | Mar 2026 | May 2026 |
| Promoter | 56.89 % | 56.89 % | 56.89 % | 54.97 % | 52.32 % | 52.32 % | 52.32 % | 46.98 % | 47.19 % | 44.99 % | 44.68 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.22 % | 30.18 % | 30.23 % | 40.12 % | 43.24 % | 42.69 % | 42.82 % | 48.66 % | 49.32 % | 50.40 % | 51.15 % |
| Others | 13.89 % | 12.93 % | 12.88 % | 4.91 % | 4.44 % | 4.99 % | 4.86 % | 4.36 % | 3.49 % | 4.61 % | 4.17 % |
| No of Share Holders | 1,165 | 836 | 868 | 1,119 | 1,153 | 1,109 | 1,094 | 1,094 | 1,093 | 1,071 | 1,076 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Sept 2024 |  Dividend | ₹ 0.33 /share | 23 Sept 2024 | 46.97 | 48.21 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 46.97 | 47.50 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 46.88 | 47.15 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 38.00 | 39.50 |
| 23 Jul 2025 |  Extraordinary General Meeting | NA | 23 Jul 2025 | 39.60 | 43.97 |
| 23 Sept 2025 | Dividend | ₹ 0.35 /share | 23 Sept 2025 | 45.00 | 43.27 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 45.00 | 44.00 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 41.50 | 41.86 |
Announcements
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015
Receipt Work Order Pursuant To Tender Process.
10 hrs ago
10 hrs agoIntimation Under Regulation 30 For Successfully Conducted A CME Programme In Patna Bihar On 11Th May 20262 days ago
2 days agoIntimation Under Regulation 30 Of SEBI (LODR) Regulation 2015- New Product Launch.4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Conversion of Securities10 days ago
10 days agoBoard Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday May 05 2026 For Conversion Of 111000 Warrants Into 111000 Equity Shares Of Face Value Of Rs. 10/-10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Conversion of SecuritiesMay 01, 2026
May 01, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday May 01 2026.May 01, 2026
May 01, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 29, 2026
Apr 29, 2026Intimation Under Regulation 30 Update On Export OperationApr 16, 2026
Apr 16, 2026Intimation Under Regulation 30 Hired Senior Management Personnel In Line With Business Expansion PlansApr 15, 2026
Apr 15, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Apr 14, 2026Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclousure Requirements ) Regulation 2015 For Hiring Of Senior Management Personnel In Line With Business Expansion PlansApr 07, 2026
Apr 07, 2026Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements ) Regulation 2015 Reciept Of Negotiation Meeting Intimation From Verka Dairies ( Punjab State Co Operative Milk Producers Federation Limited )Apr 06, 2026
Apr 06, 2026Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclousures Requirements) Regulations 2015 Positive Customer Feedback On Companies ProductsApr 02, 2026
Apr 02, 2026Intimation Under Regulation 30 Of SEBI ( LODR ) New Product Now Available In The MarketApr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Intimitation Under Regulation 30 Third Party Food Safety Audit Under FSSAI Regulatory FrameworkMar 18, 2026
Mar 18, 2026Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements) Regulation 2015 - Appointment Of Investor Relation And Public Relation AuthorityMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 12, 2026
Mar 12, 2026Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMar 07, 2026
Mar 07, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday March 07 2026Mar 07, 2026
Mar 07, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJan 27, 2026
Jan 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJan 23, 2026
Jan 23, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Jan 16, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 16, 2025
Dec 16, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 15, 2025
Dec 15, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 12, 2025
Dec 12, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesNov 17, 2025
Nov 17, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday November 17 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only)
Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-AllotmentNov 15, 2025
Nov 15, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 15 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only)Nov 15, 2025
Nov 15, 2025Intimation With Regards To Shelter Pharma Received ISO 22000:2018 CertificationNov 11, 2025
Nov 11, 2025Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 10, 2025
Nov 10, 2025Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025Nov 10, 2025
Nov 10, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025Nov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 06, 2025
Nov 06, 2025Board Meeting Intimation for Board Meeting Intimation For Board Meeting To Be Held On 10Th November 2025Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 16, 2025
Oct 16, 2025Board Meeting Outcome for 861000 Equity Shares Allotted Pursuant To Conversion Of Warrants
Oct 16, 2025
Oct 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 03, 2025
Oct 03, 2025Board Meeting Outcome for 1128000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.Oct 03, 2025
Oct 03, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 01, 2025
Oct 01, 2025Board Meeting Outcome for Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.Oct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Sep 30, 2025Technical Indicators
RSI(14)
Neutral 51.79
ATR(14)
Less Volatile 1.77
STOCH(9,6)
Neutral 56.73
STOCH RSI(14)
Neutral 52.83
MACD(12,26)
Bullish 0.25
ADX(14)
Weak Trend 10.13
UO(9)
Bearish 61.39
ROC(12)
Uptrend And Accelerating 2.85
WillR(14)
Neutral -36.61
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
